LARKSPUR, Calif.--(BUSINESS WIRE)--As previously announced, on July 16, 2023, MediPacific Sub, Inc. (“Purchaser”) and MediPacific, Inc. (“Parent”), affiliates of Foresite Capital, entered into a ...
EMERYVILLE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- As previously announced on February 16, 2024, XOMA Corporation (XOMA) entered into a merger agreement to acquire Kinnate Biopharma Inc. (KNTE) ...
SAN DIEGO--(BUSINESS WIRE)-- As previously announced on December 22, 2023, Concentra Biosciences, LLC (“Parent”) and its wholly owned subsidiary, Concentra Merger Sub II, Inc. (“Purchaser”), entered ...
We seem to discuss rights offerings ad nauseam. However, we haven't really touched on the basics of a tender offer. Instead of the disruptive nature that we see with rights offering and causing ...
Upon closing, XOMA anticipates adding approximately $9.5 million in cash to its balance sheet and several early-stage programs to potentially add to its royalty portfolio EMERYVILLE, Calif., March 19, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results